Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RH14 Inhibitors

V1RH14 inhibitors represent a chemical class designed to selectively interact with and modulate the activity of the V1RH14 receptor, a protein structure that may be implicated in various biochemical pathways. The design of V1RH14 inhibitors typically stems from a deep understanding of the receptor's binding sites, conformational flexibility, and the signaling mechanisms it controls. Scientists employ techniques such as high-throughput screening, molecular modeling, and structure-activity relationship (SAR) studies to identify and optimize molecules capable of binding to this receptor with high specificity. The inhibitors in this class may vary widely in their chemical structure, ranging from small organic molecules to larger, more complex biologics.

The development of V1RH14 inhibitors necessitates a multidisciplinary approach, combining organic chemistry, biochemistry, and pharmacology, among other fields. The inhibitors are crafted to fit precisely into the receptor's active site, effectively blocking or modulating the receptor's natural ligands from exerting their normal activity. This involves creating a compound that can maintain a high affinity for the receptor while exhibiting stability within the biological environment. The physical and chemical properties such as solubility, stability, and permeability are meticulously adjusted to ensure that these molecules can reach the receptor in adequate concentrations. V1RH14 inhibitors are characterized by their binding kinetics, which describe how quickly and tightly they interact with the receptor, and by their selectivity, which ensures that they do not significantly affect other receptors in the body, thereby minimizing off-target effects.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

AG490 is a tyrosine kinase inhibitor, particularly of JAK2. If V1RH14 is part of the JAK/STAT signaling pathway, AG490 could lead to its inhibition by preventing STAT activation and subsequent transcriptional events.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

GW5074 is a potent inhibitor of Raf-1 kinase, which is part of the MAPK/ERK pathway. If V1RH14 functions downstream of Raf-1, inhibition by GW5074 could decrease V1RH14 activity.